Bookbot

Cancer. Principles and Practice of Oncology. vol. 1.

Autori

  • Kolektív autorov

Parametre

  • 1712 stránok
  • 60 hodin čítania

Viac o knihe

Acclaimed by the worldwide medical community as "the ultimate authority on cancer" (JAMA), Cancer: Principles and Practice of Oncology is now in its Seventh Edition. This completely revised, updated classic reflects the latest breakthroughs in molecular biology, cancer prevention, and multimodality treatment of every cancer type. New chapters examine molecular biologic techniques including proteomics, genomics, targeted therapies, RNA interference, cDNA arrays, and tissue arrays. New sections discuss bioinformatics and societal issues in oncology, including regulatory issues, telemedicine, and international differences in oncology. Coverage also includes new information on functional and metabolic imaging, vaccines, and antiangiogenesis agents.

Nákup knihy

Cancer. Principles and Practice of Oncology. vol. 1., Kolektív autorov

Jazyk
Rok vydania
1997
product-detail.submit-box.info.binding
(pevná)
Akonáhle sa objaví, pošleme e-mail.

Platobné metódy

Nikto zatiaľ neohodnotil.Ohodnotiť

Titul
Cancer. Principles and Practice of Oncology. vol. 1.
Jazyk
anglicky
Vydavateľ
Lippincott
Rok vydania
1997
Väzba
pevná
Počet strán
1712
ISBN10
039751574X
ISBN13
9780397515745
Série
Anotácia
Acclaimed by the worldwide medical community as "the ultimate authority on cancer" (JAMA), Cancer: Principles and Practice of Oncology is now in its Seventh Edition. This completely revised, updated classic reflects the latest breakthroughs in molecular biology, cancer prevention, and multimodality treatment of every cancer type. New chapters examine molecular biologic techniques including proteomics, genomics, targeted therapies, RNA interference, cDNA arrays, and tissue arrays. New sections discuss bioinformatics and societal issues in oncology, including regulatory issues, telemedicine, and international differences in oncology. Coverage also includes new information on functional and metabolic imaging, vaccines, and antiangiogenesis agents.